SPTX · Forms 3, 4, 5
Insider trades at Seaport Therapeutics, Inc.
No open-market insider buys or sells at Seaport Therapeutics, Inc. in the last 90 days; 10 filings reported awards, option exercises, tax withholding or new insiders.
Every Form 3, 4 and 5 filed for Seaport Therapeutics, Inc. (SPTX) with the SEC, newest first: who traded, their role, buy or sell, shares, price and value.
Most recent insider filings
No Form 3, 4 or 5 filings for Seaport Therapeutics, Inc. in the last 90 days. The latest ones on EDGAR:
| Date | Insider | Role | Transaction | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| Robert J. Hombach | Director | Buy | 13,000 | $18.14 | $236K | Form 4 | |
| GAP Coinvestments CDA, L.P. | Director | Became an insider (Form 3) | Form 3 | ||||
| General Atlantic (SP), L.P. | Director | Became an insider (Form 3) | Form 3 | ||||
| PureTech Health plc | 10% owner | Conversion | 12,736,014 | Form 4 | |||
| PureTech Health plc | 10% owner | Conversion | 2,681,265 | Form 4 | |||
| PureTech Health plc | 10% owner | Conversion | 965,255 | Form 4 | |||
| Daphne Zohar | Chief Executive Officer | Options or other derivatives | Form 4 | ||||
| James Healy | Director | Conversion | 1,927,159 | Form 4 | |||
| James Healy | Director | Conversion | 804,379 | Form 4 | |||
| Lauren White | Chief Financial Officer | Conversion | 6,702 | Form 4 | |||
| David E. Wheadon | Director | Options or other derivatives | Form 4 | ||||
| Sandra E Peterson | Director | Options or other derivatives | Form 4 | ||||
| Lana Gladstein | General Counsel | Conversion | 33,515 | Form 4 |
Buy and Sell are open-market purchases and sales (transaction codes P and S), the trades investors watch. Awards, option exercises, tax withholding and gifts are reported too but are not market trades.